Feb. 22, 2021 Peabody, Mass. – JEOL USA introduces a new configuration of its bestselling broad ion beam milling instrument, the Cross-section Polisher (CP). The CP is widely used for preparing pristine samples prior to high resolution imaging and elemental analysis with the Scanning Electron Microscope (SEM). The upgraded configuration includes high-speed milling, sputter coating, cryo-preparation... Read more
Torrance, Calif. (February 22, 2021) – Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, announces the launch of the bioZen Nano 75 µm LC Columns to the existing portfolio of bioZen biological workflow products. The New bioZen Nano Columns offers a powerful combination two advanced particle platforms,... Read more
Feb. 22, 2021 Peabody, Mass. – JEOL USA introduces a new configuration of its bestselling broad ion beam milling instrument, the Cross-section Polisher (CP). The CP is widely used for preparing pristine samples prior to high resolution imaging and elemental analysis with the Scanning Electron Microscope (SEM). The upgraded configuration includes high-speed milling, sputter coating, cryo-preparation (down... Read more
02/19/2021 Palaiseau, Saclay Campus, France – HORIBA and GreenTropism have signed, 4th January 2021, a collaboration agreement. The two companies will combine their technologies for the development and commercialization of smart solutions combining HORIBA’s spectroscopic and hyperspectral imaging and GreenTropism’s data processing methods enhanced and automated by Artificial Intelligence. This collaboration will allow their respective and... Read more
Luminex® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry. Luminex Receives BARDA Funding to Support Development and Validation of Test Combining SARS-CoV-2 and Flu/RSV Respiratory Panel Feb 19, 2021 6:30 AM EST ARIES® Assay will simultaneously detect influenza A/B, RSV, and SARS-CoV-2 in a single test,... Read more
TÜBINGEN, Germany–(BUSINESS WIRE)–February 19, 2021 — Illumina, Inc. (Nasdaq: ILMN) today announced an agreement with the Institute of Medical Genetics and Applied Genomics at the University Hospital of Tübingen to assess the value of whole-genome sequencing (WGS) as a first-line diagnostic test for patients with genetic diseases and familial cancer syndromes. Illumina will support the... Read more
Torrance, Calif. (February 19, 2021) – Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences introduces Zebron™ ZB-Dioxin . Zebron ZB-Dioxin joins Phenomenex’s large family of GC unlimited Phase to deliver optimal performance when analyzing regulated 2,3,7,8-tetrachlorodibenzo- para-dioxin (2,3,7,8-TCDD) and 2,3,7,8 tetrachlorodibenzo- para-furan(TCDF). EPA-1613 and EPA-8290 Dioxin methods requires... Read more
Kit marks first of multiple planned for 2021 aimed at COVID-19 SANTA CLARA, Calif., February 18, 2021 Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit intended for the qualitative detection of immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum or plasma. The kit, which... Read more